The APAC Balloon Catheter Market Size was valued at USD 0.89 billion in 2021. It is projected to grow at a CAGR of 13.21%, to reach USD 1.65 billion by 2026 during the forecast period 2021 to 2026.
The balloon catheters market is being driven by increased cardiac diseases and an aging population in this area, as India and China have the world's most significant and second-largest people, respectively, with an aging population.
The rise in the frequency of peripheral vascular disorders, together with new advancements and improvements in catheterization technology, is also expected to drive market growth. Further, the advances in angioplasty and the rising incidence of coronary artery disease are projected to drive market growth.
In addition, the growing popularity of more minor invasive procedures is projected to enhance the demand for balloon catheters in developing countries. Over the projected period, the increasing need for minimally invasive treatments and technologically improved interventions for better clinical outcomes is expected to propel market growth.
Moreover, the initiatives of the government and non-government organizations to raise awareness about cardiovascular illnesses are likely to drive market expansion throughout the forecast period.
The occlusion balloon catheter market is more fragmented, with many players. Players in the market are focusing their efforts on new product development and launches to expand their market share. They are also using various strategies such as mergers and acquisitions to maintain their market position, expanding market growth.
Efforts and investments like these aid market expansion in developed countries. Also, the other type of occlusion balloon catheters is used in cardiac and peripheral procedures, increasing the market growth.
An increase in the high costs of catheterization devices and procedures, as well as due to the lack of skilled individuals, are limiting the market growth. Also, due to risk of infections and reimbursement issues, as well as an increase in the alternatives available in the market, are affecting the market growth of the balloon catheter.
This research report on the Asia Pacific Balloon Catheter Market has been segmented and sub-segmented into the following categories.
By Product Type:
By Raw Material:
By Disease Indication:
By End User:
By Country:
The Asia Pacific balloons catheters market is one of the fastest markets over the years, globally. It is expected to grow more significantly in the coming years due to the rising frequency of diabetes and other diseases related diseases across the region. In addition, Asia Pacific is anticipated to grow at a significant rate due to ongoing changes in lifestyles that lead to vascular diseases and expanding healthcare infrastructure.
Moreover, the increase in the geriatric population as India and China has the largest population with the rising elderly population significantly contributes to the APAC regional market growth. Furthermore, increased demand for minimally invasive treatments and significant healthcare spending in emerging nations such as India & China are likely to propel regional market growth.
The China balloon catheter market dominated the market, and it is more likely to continue its growth throughout the forecast period. The expansion of chronic diseases such as diabetes, heart attack, and other connected ailments is contributed to the market's rise. Also, with the increase in the high blood cholesterol levels, and the number of coronary artery bypass procedures, China is anticipated to increase the market growth and continue to rise at the fastest rate during the forecast period.
On the other hand, the countries such as Japan's balloon catheter market and India's balloon catheter market are projected to witness a promising share in the balloon catheters market during the forecast period. They were improving healthcare facilities, availability of technology & infrastructure, patient awareness, and growing healthcare expenditure fuel market growth in these countries.
Top Companies leading the Asia Pacific Balloon Catheter Market Profiled in the Report are B. Braun Melsungen AG, Abbott Vascular, Terumo Medical, Corp., Medtronic, Biosensors International, Ltd., Boston Scientific, Goodman, and Cordis.MicroPort Scientific, Corp., Simeks Medical, and AngioScore, Inc.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Normal Balloon Catheter
5.1.3 Stent Graft Balloon Catheter
5.1.4 Drug Eluting Balloon Catheter
5.1.5 Scoring Balloon Catheter
5.1.6 Cutting Balloon Catheter
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Raw Material
5.2.1 Introduction
5.2.2 Polyurethane
5.2.3 Nylon
5.2.4 Others
5.2.5 Y-o-Y Growth Analysis, By Raw Material
5.2.6 Market Attractiveness Analysis, By Raw Material
5.2.7 Market Share Analysis, By Raw Material
5.3 End-User
5.3.1 Introduction
5.3.2 Public Hospitals & Private Hospitals
5.3.3 Cardiac Catheterisation Laboratories
5.3.4 Ambulatory Surgical Centres
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
5.4 Disease Indications
5.4.1 Introduction
5.4.2 Coronary Artery Disease
5.4.3 Peripheral Vascular Disease
5.4.4 Y-o-Y Growth Analysis, By Disease Indications
5.4.5 Market Attractiveness Analysis, By Disease Indications
5.4.6 Market Share Analysis, By Disease Indications
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Raw Material
6.1.3.4 By End User
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Raw Material
6.1.4.4 By End User
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Raw Material
6.1.5.4 By End User
6.1.5.5 By Indication
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Boston Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic
8.3 Terumo Corporation
8.4 B. Braun Melsungen AG
8.5 Jotech GmbH
8.6 Meril Life Pvt. Ltd.
8.7 Abbott Laboratories
8.8 Biosensors International Ltd
8.9 Cook Medical Inc.
8.10 Cordis Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
